Long Non-Coding RNA CDKN2B-AS1 Facilitates Laryngeal Squamous Cell Cancer Through Regulating miR-497/CDK6 Pathway

Xiangyan Cui1, Tingting Yu1, Jing Shang1

  • 1Department of Otolaryngology-Head and Neck Surgery, The First Hospital of Jilin University, Changchun 130021, People's Republic of China.

Oncotargets and Therapy
|November 23, 2019
PubMed
Abstract

Insights

CDKN2B-AS1 is upregulated in laryngeal squamous cell cancer (LSCC) and promotes tumor growth by regulating the miR-497/CDK6 axis. This long noncoding RNA may be a potential therapeutic target for LSCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Long noncoding RNA CDKN2B-AS1 (antisense RNA 1) is implicated in various cancers.
  • Its specific functions and regulatory mechanisms in laryngeal squamous cell cancer (LSCC) are not well understood.

Purpose of the Study:

  • To investigate the biological roles of CDKN2B-AS1 in LSCC.
  • To elucidate the underlying regulatory mechanisms of CDKN2B-AS1 in LSCC progression.

Main Methods:

  • Real-time quantitative PCR (qRT-PCR) to measure expression of CDKN2B-AS1, miR-497, and CDK6 in LSCC tissues and cell lines.
  • Functional assays to assess the impact of CDKN2B-AS1 on LSCC cell proliferation, apoptosis, migration, and invasion.
  • Bioinformatics analysis and luciferase activity assays to determine the interaction between CDKN2B-AS1 and miR-497.

Main Results:

  • CDKN2B-AS1 expression is significantly elevated in LSCC tissues compared to normal tissues.
  • High CDKN2B-AS1 levels correlate with lymph node metastasis and advanced clinical stage.
  • CDKN2B-AS1 knockdown inhibits LSCC cell proliferation, induces apoptosis, and suppresses migration and invasion.
  • CDKN2B-AS1 acts as an oncogenic lncRNA in LSCC by regulating the miR-497/CDK6 axis.

Conclusions:

  • CDKN2B-AS1 plays an oncogenic role in LSCC tumorigenesis via the miR-497/CDK6 pathway.
  • CDKN2B-AS1 represents a potential therapeutic target for LSCC treatment.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K